THE CANCER THERAPY METAVERSE
DEAD

Serial Number

97200607

Owner

Rocket Wellness Inc.

Attorney

Austin Padgett

Filing Date

Jan 3, 2022

Add to watchlist:

No watchlists yet
View on USPTO

THE CANCER THERAPY METAVERSE Trademark

Serial Number: 97200607

THE CANCER THERAPY METAVERSE is a trademark filed by Rocket Wellness Inc. on January 3, 2022. The trademark is classified under Class 9 (Computers & Electronics). The application is currently no longer active.

Owner Contact Info

Rocket Wellness Inc. (8 trademarks)

c/o Troutman Pepper, Attn: Austin Padget
Atlanta, GA 30308

Entity Type: 03

Trademark Details

Filing Date

January 3, 2022

Registration Date

Not Registered

Goods & Services

Downloadable software for healthcare providers and patients for use in connection with the treatment of pain and anxiety, tracking patient activity and biometric markers; virtual reality headsets; Downloadable computer software for treating psychological and related physiological comorbidities of severe acute and chronic diseases; computer peripheral devices; Virtual reality headsets and helmets adapted for medical and therapeutic purposes; {indicate format e.g., downloadable} computer application software for the development, deployment, and operation of patient-directed software in the field of digital therapeutics and treatment support; {indicate format e.g., downloadable} computer application software for targeting, monitoring, intervening, and managing human health conditions, behaviors, and disease

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jun 21, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 21, 2024 ABN2
CORRESPONDENCE E-MAILED
Mar 4, 2024 GRML
SUBSEQUENT FINAL REFUSAL WRITTEN
Mar 4, 2024 CFRC
CORRESPONDENCE E-MAILED
Mar 4, 2024 GRML
ACTION CONTINUING A FINAL - COMPLETED
Mar 4, 2024 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 4, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 4, 2024 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Dec 8, 2023 GNS1
SUBSEQUENT FINAL EMAILED
Dec 8, 2023 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Dec 8, 2023 CFRC
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 14, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 14, 2023 GNRN
NON-FINAL ACTION E-MAILED
Aug 14, 2023 GNRT
NON-FINAL ACTION WRITTEN
Aug 14, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 11, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 11, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 11, 2023 GNFN
FINAL REFUSAL E-MAILED
May 11, 2023 GNFR
FINAL REFUSAL WRITTEN
May 11, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 11, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 11, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 11, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 12, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 12, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 12, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 6, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2022 NWOS